MarketInOut Stock Screener Log In | Sign Up

Affymax Inc

OTC • Healthcare • Biotechnology • Quote as of 10/28/2026
Affymax Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeOTC
Market Capitalization0.03 mln
Float36.96 mln

Relative Strength

1 / 100
Severely lagging

Pre-Tax Margin

-1,211%
Severely loss-making

ROE

112
Extraordinary

ROA

-229
Deeply negative

Business Description

Affymax Inc. is a New York-based company founded in 2001 that no longer carries out meaningful business activity. It formerly worked on medications aimed at helping patients in the United States manage severe and potentially fatal illnesses.

Key Fundamentals

EPS-38.21
ROE112
RPS0.00
ROIC917
ROA-229
Interest Cover-9.61
EBITDA, mln-47.65
EV / EBITDA0.07
Revenue, mln0.04

Quote Details

Last 0.0008
Change 0 (0%)
Open 0.0008
Volume 170
Turnover 0.136
Average Volume 3,504.43

Financial Ratios

Pre-Tax Profit Margin-1,211
Current Ratio20.81
Price / Book0.01
Price / Sales0.02

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -50% 1 / 100   
1 Month 14.29% 91 / 100   
2 Months 0% 56 / 100   
6 Months -66.67% 7 / 100   
1 Year 167% 96 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog